NEUROCRINE BIOSCIENCES INC
NBIX
71 insider filings · Latest: Sep 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jun 8 10:07 PM | Leslie V NorwalkDirector | Sale | 1,250 | $168.06 | $210.1K | 2,838(D) | View → |
| Jun 5, 2026 | Jun 5 8:31 PM | STEPHEN SHERWIN | Proposed Sale | 25,000 | $167.35 | $4.2M | — | View → |
| Jun 2, 2026 | Jun 4 10:02 PM | Julie CookeChief Human Resources Officer | Sale | 36,937 | $156.22 | $5.8M | 22,374(D) | View → |
| Jun 1, 2026 | Jun 2 10:08 PM | Jude OnyiaChief Scientific Officer | Sale | 11,000 | $160.25 | $1.8M | 25,846(D) | View → |
| May 29, 2026 | Jun 2 10:03 PM | Ingrid DelaetChief Regulatory Officer | Sale | 2,261 | $156.71 | $354.3K | 16,225(D) | View → |
| Jun 2, 2026 | Jun 2 8:39 PM | JULIE COOKE | Proposed Sale | 36,937 | $161.00 | $5.9M | — | View → |
| Jun 1, 2026 | Jun 1 8:25 PM | JUDE ONYIA | Proposed Sale | 11,000 | $158.30 | $1.7M | — | View → |
| May 27, 2026 | May 29 10:09 PM | Jude OnyiaChief Scientific Officer | Sale | 11,000 | $155.53 | $1.7M | 25,846(D) | View → |
| May 29, 2026 | May 29 8:25 PM | INGRID DELAET | Proposed Sale | 2,261 | $156.39 | $353.6K | — | View → |
| May 26, 2026 | May 28 10:08 PM | David W. BoyerChief Corp. Affairs Officer | Sale | 3,888 | $156.64 | $609.0K | 7,799(D) | View → |
| May 27, 2026 | May 27 8:33 PM | JUDE ONYIA | Proposed Sale | 11,000 | $155.73 | $1.7M | — | View → |
| May 26, 2026 | May 26 8:45 PM | DAVID WARREN BOYER | Proposed Sale | 3,888 | $156.70 | $609.2K | — | View → |
| May 19, 2026 | May 21 9:49 PM | Kevin Charles GormanDirector | Sale | 245,088 | $154.33 | $37.8M | 511,293(D) | View → |
| May 19, 2026 | May 19 8:31 PM | KEVIN CHARLES GORMAN | Proposed Sale | 245,088 | $157.21 | $38.5M | — | View → |
| May 15, 2026 | May 18 9:50 PM | POPS RICHARD FDirector | Sale | 15,000 | $157.65 | $2.4M | 34,480(D) | View → |
| May 15, 2026 | May 15 8:33 PM | RICHARD F POPS | Proposed Sale | 15,000 | $159.05 | $2.4M | — | View → |
| May 12, 2026 | May 14 8:45 PM | Leslie V NorwalkDirector | Sale | 3,810 | $155.01 | $590.6K | 2,429(D) | View → |
| May 12, 2026 | May 12 6:35 PM | Norwalk Leslie V | Proposed Sale | 6,310 | $162.92 | $1.0M | — | View → |
| Jan 16, 2026 | Jan 20 11:56 PM | Kyle GanoDirector, Chief Executive Officer | Sale | 36,400 | $132.70 | $4.8M | 140,407(D) | View → |
| Jan 16, 2026 | Jan 16 9:21 PM | KYLE GANO | Proposed Sale | 36,400 | $133.35 | $4.9M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 17 10:44 PM | Kevin Charles GormanDirector | Option Exercise | 10,981 | — | 5,377(D) | View → |
| Feb 13, 2026 | Feb 17 10:44 PM | Sanjay Chandru KeswaniChief Medical Officer | Grant/Award | 42,112 | $124.12 | 6,285(D) | View → |
| Jan 31, 2026 | Feb 3 11:22 PM | David W. BoyerChief Corp. Affairs Officer | Option Exercise | 2,096 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:21 PM | Eric BenevichChief Commercial Officer | Option Exercise | 2,294 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:06 PM | Matt AbernethyChief Financial Officer | Option Exercise | 2,437 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:05 PM | Julie CookeChief Human Resources Officer | Option Exercise | 1,741 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:04 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 801 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:03 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 2,927 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:02 PM | Kevin Charles GormanDirector | Option Exercise | 5,142 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Darin LippoldtChief Legal Officer | Option Exercise | 2,373 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 238 | — | 0(D) | View → |
| Jan 16, 2026 | Jan 20 11:56 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 36,400 | $35.99 | 0(D) | View → |
← Previous
Page 4 of 4